Education
About Us
Working with TipRanks
Follow Us
Pfizer (DE:PFE)
XETRA:PFE
Ritlecitinib 100 Mg, Ritlecitinib 50 Mg
Chronic Spontaneous Urticaria
Phase II
Not Yet Recruiting
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Oct 20, 2025
―
Pf-08049820
Atopic Dermatitis, Eczema, Atopic
Phase II
Not Yet Recruiting
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Oct 09, 2025
―
Atirmociclib (Pf-07220060)
Healthy Volunteer
Phase I
Not Yet Recruiting
Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants
Oct 08, 2025
―
Sasanlimab, Bcg, Pf-08052667, Pf-02921367
Non-Muscle Invasive Bladder Cancer
Phase I
Not Yet Recruiting
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Sep 25, 2025
―
Carbamazepine, Pf-07248144
Healthy Adults
Phase I
Recruiting
A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144
Sep 25, 2025
―
Midazolam, Pf-08049820, Dabigatran Etexilate, Portia (Ee And Ln) Or Equivalent Oral Tablet
Atopic Dermatitis
Phase I
Recruiting
A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants
Sep 02, 2025
―
Itraconazole, Probenecid, Pf-07220060
Healthy Adults
Phase I
Not Yet Recruiting
A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060
Aug 29, 2025
―
Pf-08049820 Mr1, Pf-08049820 Mr2, Pf-08049820 Ir
Atopic Dermatitis
Phase I
Active Not Recruiting
A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults
Aug 28, 2025
―
Pf-08046054, Docetaxel Monotherapy
Non-small Cell Lung Carcinoma, Non-Small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase III
Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Aug 20, 2025
―
Pediarix, Prevnar 20, Multivalent Group B Streptococcus Vaccine, Infanrix Hexa, Infanrix, Prevenar 20
Healthy
Phase III
Recruiting
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Aug 14, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Pfizer (PFE) have in its pipeline
PFE is currently developing the following drugs: Ritlecitinib 100 Mg, Ritlecitinib 50 Mg, Pf-08049820, Atirmociclib (Pf-07220060). These drug candidates are in various stages of clinical development as the company works toward FDA approval.